| 000 | 00000nam##2200000za#4500 |
| 001 | 9.647224 |
| 003 | CaOODSP |
| 005 | 20200330140426 |
| 007 | ta |
| 008 | 150407|1998||||xxc||||| f|0| 0 eng|d |
| 020 | |a0-662-27482-2 |
| 040 | |aCaOODSP|beng |
| 043 | |an-cn--- |
| 086 | 1 |aRG79-4/1-1998E |
| 110 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
| 245 | 10|aRoad map for the next decade : |breport on the PMPRB's public consultations |
| 260 | |aOttawa - Ontario : |bPatented Medicine Prices Review Board |c1998. |
| 300 | |a34p. in various pagings. : |bgraphs, tables ; |c28 cm. |
| 500 | |aContents: Message from the Board.--Context.--What stakeholders are saying about Canada's pharmaceutical policy and the PMPRB's mandate.--What stakeholders are saying about how the Board carries out its mandate.--Action plan for follow-up on issues raised by stakeholders.--Conclusion.--Appendices. Accompanied by: Highlights.--Consultation policy.--PMPRB research agenda: 1998-2000.--PMPRB Study series S-9811: Trends in patented veterinary medicine prices. drug prices.--U.S. prices: preliminary outline of issues.--Notice and comment: regulating patented veterinary medicine prices. Department of Veterans Affairs formulary.--Price review process: preliminary outline of issues.--Category 3 drug prices: preliminary outline of issues.--Notice and comment: regulating patented veterinary medicine prices. |
| 563 | |aSoftcover |
| 590 | |a99-01|b1999-01-08 |
| 690 | 07|aDrugs|2gcpds |
| 690 | 07|aPatents|2gcpds |
| 690 | 07|aPrices|2gcpds |
| 775 | 08|tLe guide pour la prochaine décennie : |w(CaOODSP)9.680649 |
| 776 | 0#|tRoad map for the next decade : |w(CaOODSP)9.698387 |